EDITORIAL
Published on 08 May 2019
Editorial: Management of Immune-Related Adverse Events for Patients Undergoing Treatment With Checkpoint Inhibitors
doi 10.3389/fonc.2019.00365
- 1,980 views
- 3 citations
- Frontiers in Oncology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Management of Immune-Related Adverse Events for Patients Undergoing Treatment with Checkpoint Inhibitors
Management of Immune-Related Adverse Events for Patients Undergoing Treatment with Checkpoint Inhibitors
7,624
Total downloads
30k
Total views and downloads
Articles
SYSTEMATIC REVIEW
Published on 11 Dec 2018
The Relative Risk and Incidence of Immune Checkpoint Inhibitors Related Pneumonitis in Patients With Advanced Cancer: A Meta-Analysis
doi 10.3389/fphar.2018.01430
- 7,527 views
- 109 citations
CASE REPORT
Published on 25 Sep 2018
Management of Persistent Pruritus and Lichenoid Reaction Secondary to Nivolumab With Narrowband Ultraviolet B Phototherapy
doi 10.3389/fonc.2018.00405
- 7,824 views
- 17 citations
REVIEW
Published on 22 Mar 2018
Immune Dysregulation in Cancer Patients Undergoing Immune Checkpoint Inhibitor Treatment and Potential Predictive Strategies for Future Clinical Practice
doi 10.3389/fonc.2018.00080
- 4,573 views
- 40 citations
REVIEW
Published on 15 Nov 2017
Checkpoint Blockade Toxicity and Immune Homeostasis in the Gastrointestinal Tract
doi 10.3389/fimmu.2017.01547
- 8,541 views
- 140 citations
Published in
Frontiers in Oncology
Pharmacology of Anti-Cancer Drugs
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Immunology
- 5.7 impact factor
- 9.8 citescore
Frontiers in Pharmacology
- 4.4 impact factor
- 7.8 citescore